Denna sida på svenska
Loading profile information...

About me

I am a biostatistician, working with statistical methods for cancer epidemiology. My main research interest is cancer patient survival and I have published high impact studies on cancer patient survival for a range of cancer sites. I develop statistical methods, including user-friendly software to facilitate wide application of the methods, as well as apply the methods to register-based data to answer important epidemiological and clinical research questions. I believe that an important task for biostatisticians is to communicate the results from complicated statistical methods in a way that is understandable for other researchers, clinicians and healthcare policymakers. Therefore, I put a lot of emphasis on communication and presentation of complex methods in an understandable way. I’m currently working in several projects, a description of the projects I’m most heavily involved with currently are described below.

Education

  • 2013, PhD (Medical Sciences), Karolinska Institutet. Title of thesis: Quantifying cancer patient survival; extensions and applications of cure models and life expectancy estimation
  • 2007, MSc (Mathematical statistics), Uppsala University.

Postdoc

  • 2014 – 2015:  Postdoc at the department of medical epidemiology and biostatistics (MEB), KI, working with Keith Humphreys. A project on models for breast cancer tumor growth, micro simulation of the natural history of breast cancer and mammography screening.
  • 2015 – 2016:  Postdoc at the department of Documentation & Quality, Danish Cancer Society working with Hans Storm and Gerda Engholm. A project on estimation of avoidable cancers in the Nordic countries.

Research description

Survival after hematological cancers, with a focus on MPN
I am part of a successful collaborative group of hematologists and biostatisticians at KI. We have been studying the prognosis of a range of hematological malignancies, many of the studies have been published in high-impact journals. I have lately taken a more senior role in the group, and given more responsibility for the research on myeloproliferative neoplasms (MPN), as well as the methods development. Compared to many other hematological malignancies MPNs are rather indolent diseases. Despite efforts to optimize treatment and prophylactic measures, patients with MPNs have a shorter survival than the general population and experience complications, such as thromboembolism and bleedings, due to their MPN. There are few population-based studies on MPNs, and most studies are small with short follow-up time and do not include population controls. It is therefore of great importance to gain a further understanding of the disease trajectory and risk of complications for this group of patients. By taking advantage of the Swedish health registers and novel statistical methods, we will improve the understanding of the clinical course and prognosis among MPN patients.

 

International Cancer Benchmarking Partnership
I am working within a high profile international collaborative project on cancer patient survival, the International Cancer Benchmarking Partnership, run by the International Agency for Research on Cancer (IARC) in Lyon in collaboration with renowned experts in the field. The ICBP is an international cancer survival comparison study focused on measuring differences and understanding factors that drive these. I am investigating how much of differences observed in population-based cancer patient survival between countries that is due to differences in reporting to the cancer registries. There are for example differences in the definition of date of diagnosis, definitions and inclusion of multiple primaries and death certificate initiated cases. This is investigated using simulations as well as by analyzing register-based data.

 

Avoidable cancers in the Nordic countries

This is a continuation of my postdoc at the Danish Cancer Society, working in a Nordic project on avoidable cancers. The aim of this project is to estimate how much of the future cancer burden in the Nordic countries is avoidable by changes in the prevalence of overweight/obesity, smoking, alcohol consumption and physical activity. We estimate the population attributable fractions (PAFs) of the four mentioned risk factors on (various sites of) cancer as well as 30-year projections of cancer incidence under different interventions to change risk factor prevalence.

 

Current doctoral students

  • Co-supervisor of Anna Ravn Landtblom, registered at Department of Medicine, Solna, KI in Dec 2016.
  • Co-supervisor of Maximilian Zoltek, registered at the Department of Molecular Medicine and Surgery, KI in May 2017.
  • Co-supervisor of Qianwei Liu with planned registration at MEB Spring 2018.

Former PhD students

  • Co-supervisor of Hannah Bower, dissertation March 23 2018.

Teaching portfolio

I have been involved in teaching and/or course organising of:

  • Survival analysis (biostat III), within the Doctoral Programme in Epidemiology
  • Data Management within epidemiological research, including lectures on laws and regulations concerning the use of personal data in research
  • Competing risks and multistate models
  • IARC summer school on cancer epidemiology, module 1, cancer survival methods for cancer registries, June 2015, Lyon, France.
  • Summer school on modern methods in biostatistics and epidemiology. Survival analysis using Stata (a 1-day course) and Statistical Methods for Population-based Cancer Survival (a 1-week course). Treviso, Italy.
  • Workshops on epidemiological designs and cancer survival analysis
  • Pre-conference courses on Statistical Methods for Population-based Cancer Survival
  • Biostatistics/evidence based medicine within the medical program at KI

Publications

Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status
Bower H, Andersson Tm, Crowther Mj, Dickman Pw, Lambe M, Lambert Pc
American journal of epidemiology 2018;187(4):828-836

Avoidable cancers in the Nordic countries-The impact of alcohol consumption
Andersson Tm, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, et al
European journal of cancer (Oxford, England : 1990) 2018;103():299-307

Avoidable colorectal cancer cases in Denmark - The impact of red and processed meat
Lourenço S, Gunge Vb, Andersson Tm, Andersen Cle, Lund Aq, Køster B, et al
Cancer epidemiology 2018;55():1-7

Development in sunburn 2007-2015 and skin cancer projections 2007-2040 of campaign results in the Danish population
Køster B, Meyer M, Andersson T, Engholm G, Dalum P
Medicine 2018;97(41):e12738-

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S, Jerkeman M, Andersson Po, Enblad G, Wahlin Be, Hasselblom S, et al
American journal of hematology 2018;():-

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Reutfors J, Andersson Tm, Brenner P, Brandt L, Dibernardo A, Li G, et al
Journal of affective disorders 2018;238():674-679

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
Hultcrantz M, Björkholm M, Landgren O, Kristinsson Sy, Andersson Tml
Annals of internal medicine 2018;169(4):268-

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study
Hultcrantz M, Björkholm M, Dickman Pw, Landgren O, Derolf År, Kristinsson Sy, et al
Annals of internal medicine 2018;168(5):317-325

Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Landtblom Ar, Bower H, Andersson Tm, Dickman Pw, Samuelsson J, Björkholm M, et al
Leukemia 2018;32(10):2203-2210

Skin cancer projections and cost savings 2014-2045 of improvements to the Danish sunbed legislation of 2014
Køster B, Meyer Mkh, Andersson Tm, Engholm G, Dalum P
Photodermatology, photoimmunology & photomedicine 2018;():-

Sunbed use 2007-2015 and skin cancer projections of campaign results 2007-2040 in the Danish population: repeated cross-sectional surveys
Køster B, Meyer Mk, Andersson Tm, Engholm G, Dalum P
BMJ open 2018;8(8):e022094-

Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period-The effect of envisaged scenarios changing smoking prevalence
Andersson Tm, Engholm G, Brink Al, Pukkala E, Stenbeck M, Tryggvadottir L, et al
European journal of cancer (Oxford, England : 1990) 2018;103():288-298

Tumor characteristics and prognosis in women with pregnancy-associated breast cancer
Johansson Alv, Andersson Tm, Hsieh Cc, Jirström K, Cnattingius S, Fredriksson I, et al
International journal of cancer 2018;142(7):1343-1354

Assessment of lead-time bias in estimates of relative survival for breast cancer
Andersson Tm, Rutherford Mj, Humphreys K
Cancer epidemiology 2017;46():50-56

Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity
Andersson Tm, Weiderpass E, Engholm G, Lund Aq, Olafsdottir E, Pukkala E, et al
European journal of cancer (Oxford, England : 1990) 2017;79():106-118

Corrigendum to "Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118]
Andersson Tm, Weiderpass E, Engholm G, Lund Aq, Olafsdottir E, Pukkala E, et al
European journal of cancer (Oxford, England : 1990) 2017;87():219-220

Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England
Syriopoulou E, Bower H, Andersson Tm, Lambert Pc, Rutherford Mj
British journal of cancer 2017;117(9):1419-1426

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
Strand F, Humphreys K, Eriksson M, Li J, Andersson Tm, Törnberg S, et al
International journal of cancer 2017;140(1):34-40

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach
Andersson Tm, Crowther Mj, Czene K, Hall P, Humphreys K
American journal of epidemiology 2017;186(9):1065-1073

Reply to D. Pulte et al
Bower H, Björkholm M, Dickman Pw, Höglund M, Lambert Pc, Andersson Tm
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017;35(6):696-697

Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study
Song H, Fang F, Valdimarsdóttir U, Lu D, Andersson Tm, Hultman C, et al
BMC cancer 2017;17(1):2-

Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden
Lu D, Andersson Tm, Fall K, Hultman Cm, Czene K, Valdimarsdóttir U, et al
JAMA oncology 2016;2(9):1188-96

Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
Bower H, Andersson Tm, Björkholm M, Dickman Pw, Lambert Pc, Derolf År
Blood cancer journal 2016;6():e390-

Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification
Crowther Mj, Andersson Tm, Lambert Pc, Abrams Kr, Humphreys K
Statistics in medicine 2016;35(7):1193-209

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Bower H, Björkholm M, Dickman Pw, Höglund M, Lambert Pc, Andersson Tm
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34(24):2851-7

Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach
Baade Pd, Youlden Dr, Andersson Tm, Youl Ph, Walpole Et, Kimlin Mg, et al
Cancer causes & control : CCC 2016;27(8):955-64

The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study
Eriksson H, Lyth J, Andersson Tm
International journal of cancer 2016;138(12):2829-36

Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia
Karlsson Ik, Bennet Am, Ploner A, Andersson Tm, Reynolds Ca, Gatz M, et al
Neurobiology of aging 2015;36(4):1751-1756

Cancer during pregnancy and the postpartum period: A population-based study
Andersson Tm, Johansson Al, Fredriksson I, Lambe M
Cancer 2015;121(12):2072-7

Estimating the change in life expectancy after a diagnosis of cancer among the Australian population
Baade Pd, Youlden Dr, Andersson Tm, Youl Ph, Kimlin Mg, Aitken Jf, et al
BMJ open 2015;5(4):e006740-

Family history and risk of pregnancy-associated breast cancer (PABC)
Johansson Al, Andersson Tm, Hsieh Cc, Cnattingius S, Dickman Pw, Lambe M
Breast cancer research and treatment 2015;151(1):209-17

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I, Ekberg S, Jerkeman M, Chang Et, Björkholm M, Andersson Tm, et al
American journal of hematology 2015;90(12):1128-34

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
Hultcrantz M, Wilkes Sr, Kristinsson Sy, Andersson Tm, Derolf År, Eloranta S, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(20):2288-95

The loss in expectation of life after colon cancer: a population-based study
Andersson Tm, Dickman Pw, Eloranta S, Sjövall A, Lambe M, Lambert Pc
BMC cancer 2015;15():412-

Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life
Rutherford Mj, Andersson Tm, Møller H, Lambert Pc
Cancer epidemiology 2015;39(1):118-25

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Holmes Md, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson Tm, et al
BMC cancer 2014;14():391-

Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study
Andersson Tm, Eriksson H, Hansson J, Månsson-brahme E, Dickman Pw, Eloranta S, et al
Cancer epidemiology 2014;38(1):93-9

Mortality in women with pregnancy-associated malignant melanoma
Johansson Al, Andersson Tm, Plym A, Ullenhag Gj, Møller H, Lambe M
Journal of the American Academy of Dermatology 2014;71(6):1093-101

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study
Hultcrantz M, Andersson Tml, Landgren O, Derolf Ar, Dickman Pw, Bjorkholm M, et al
BLOOD 2014;124(21)

The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival
Eloranta S, Lambert Pc, Andersson Tm, Björkholm M, Dickman Pw
Epidemiology (Cambridge, Mass.) 2014;25(5):742-8

Estimating the loss in expectation of life due to cancer using flexible parametric survival models
Andersson Tm, Dickman Pw, Eloranta S, Lambe M, Lambert Pc
Statistics in medicine 2013;32(30):5286-300

Estimating the proportion cured of cancer: Some practical advice for users
Yu Xq, De Angelis R, Andersson Tml, Lambert Pc, O'connell Dl, Dickman Pw
CANCER EPIDEMIOLOGY 2013;37(6):836-42

How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden
Eloranta S, Adolfsson J, Lambert Pc, Stattin P, Akre O, Andersson Tm, et al
Cancer causes & control : CCC 2013;24(3):505-15

Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study
Möller E, Galeone C, Andersson Tm, Bellocco R, Adami Ho, Andrén O, et al
Journal of nutritional science 2013;2():e15-

Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
Kristinsson Sy, Eloranta S, Dickman Pw, Andersson Tm, Turesson I, Landgren O, et al
American journal of hematology 2013;88(1):60-5

Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)
Johansson Al, Andersson Tm, Hsieh Cc, Jirström K, Dickman P, Cnattingius S, et al
Breast cancer research and treatment 2013;139(1):183-92

[Structuring and documenting research projects]
Eloranta S, Johansson Al, Kristinsson Sy, Andersson Tm
Lakartidningen 2013;110(8):416-9

Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study
Shah A, Andersson Tml, Rachet B, Bjorkholm M, Lambert Pc
BRITISH JOURNAL OF HAEMATOLOGY 2013;162(4):509-16

Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006)
Eloranta S, Lambert Pc, Sjöberg J, Andersson Tm, Björkholm M, Dickman Pw
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(11):1435-41

Tobacco use and cancer survival: A cohort study of 40,230 Swedish male construction workers with incident cancer
Nordenvall C, Nilsson Pj, Ye Wm, Andersson Tml, Nyren O
INTERNATIONAL JOURNAL OF CANCER 2013;132(1):155-61

Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models
Andersson Tml, Lambert Pc
STATA JOURNAL 2012;12(4):623-638

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S, Lambert Pc, Andersson Tm, Czene K, Hall P, Björkholm M, et al
BMC medical research methodology 2012;12():86-

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Hultcrantz M, Kristinsson Sy, Andersson Tml, Landgren O, Eloranta S, Derolf Ar, et al
JOURNAL OF CLINICAL ONCOLOGY 2012;30(24):2995-3001

Screening and cervical cancer cure: population based cohort study
Andrae B, Andersson Tml, Lambert Pc, Kemetli L, Silfverdal L, Strander B, et al
BMJ-BRITISH MEDICAL JOURNAL 2012;:e900-

The impact of plasma preparations and their storage time on short-term posttransfusion mortality: A population-based study using the Scandinavian Donation and Transfusion database
Norda R, Andersson Tml, Edgren G, Nyren O, Reilly M
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY 2012;72(4):954-60

The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study
Moller E, Galeone C, Adami Ho, Adolfsson J, Andersson Tml, Bellocco R, et al
PUBLIC HEALTH NUTRITION 2012;15(10):1897-908

Dietary Phytoestrogens and the Risk of Ovarian Cancer in the Women's Lifestyle and Health Cohort Study
Hedelin M, Lof M, Andersson Tml, Adlercreutz H, Weiderpass E
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2011;20(2):308-17

Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
Andersson Tml, Dickman Pw, Eloranta S, Lambert Pc
BMC MEDICAL RESEARCH METHODOLOGY 2011;:96-

Increased Mortality in Women with Breast Cancer Detected during Pregnancy and Different Periods Postpartum
Johansson Alv, Andersson Tml, Hsieh Cc, Cnattingius S, Lambe M
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2011;20(9):1865-72

Response to "Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy" by Welsby, Stafford-Smith, and Phillips-Bute
Reilly M, Nyren O, Andersson Tml, Edgren G, Norda R, Shanwell A, et al
TRANSFUSION 2011;51(2):445-446

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005
Hultcrantz Ml, Hinchliffe Sr, Kristinsson Sy, Andersson Tml, Eloranta S, Derolf Ar, et al
BLOOD 2011;118(21):1648-1649

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
Bjorkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjoberg J, et al
JOURNAL OF CLINICAL ONCOLOGY 2011;29(18):2514-20

Association Between CYP2C19 Polymorphism and Depressive Symptoms
Sim Sc, Nordin L, Andersson Tml, Virding S, Olsson M, Pedersen Nl
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 2010;153B(6):1160-6

Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000
Eloranta S, Lambert Pc, Cavalli-bjorkman N, Andersson Tml, Glimelius B, Dickman Pw
EUROPEAN JOURNAL OF CANCER 2010;46(16):2965-72

PATTERNS OF SURVIVAL AMONG 7,249 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2003
Hultcrantz L, Kristinsson S, Andersson T, Eloranta S, Derolf A, Landgren O, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2010;:470-470

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008
Hultcrantz M, Kristinsson Sy, Andersson Tml, Eloranta S, Derolf Ar, Landgren O, et al
BLOOD 2010;116(21):1266-1267

Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002
Tynell E, Andersson Tm, Norda R, Edgren G, Nyren O, Shanwell A, et al
TRANSFUSION 2010;50(6):1249-56

Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study
Andersson Tml, Lambert Pc, Derolf Ar, Kristinsson Sy, Eloranta S, Landgren O, et al
BRITISH JOURNAL OF HAEMATOLOGY 2010;148(6):918-24

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008
Bjorkholm M, Ohm L, Eloranta S, Derolf Ar, Hultcrantz M, Sjoberg J, et al
BLOOD 2010;116(21):93-94

Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
Derolf Ar, Kristinsson Sy, Andersson Tml, Landgren O, Dickman Pw, Bjorkholm M
BLOOD 2009;113(16):3666-72

Increasing Incidence of Pregnancy-Associated Breast Cancer in Sweden
Andersson Tml, Johansson Alv, Hsieh Cc, Cnattingius S, Lambe M
OBSTETRICS AND GYNECOLOGY 2009;114(3):568-72

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
Kristinsson Sy, Bjorkholm M, Andersson Tml, Eloranta S, Dickman Pw, Goldin Lr, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;94(12):1714-20

PATTERNS OF SURVIVAL AND CAUSES OF DEATH FOLLOWING A DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED STUDY
Kristinsson Sy, Bjorkholm M, Andersson Tml, Eloranta S, Dickman Pw, Goldin Lr, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;:157-157

Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma
Shanwell A, Andersson Tml, Rostgaard K, Edgren G, Hjalgrim H, Norda R, et al
VOX SANGUINIS 2009;96(4):316-23

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study
Derolf Ar, Andersson Tml, Lambert Pc, Kristinsson Sy, Eloranta S, Landgren O, et al
BLOOD 2009;114(22):561-561

Temporal trends in the proportion cured for cancer of the colon and rectum: A population-based study using data from the Finnish Cancer Registry
Lambert Pc, Dickman Pw, Osterlund P, Andersson T, Sankila R, Glimelius B
INTERNATIONAL JOURNAL OF CANCER 2007;121(9):2052-9

Show all publications

Map